ASMB
Assembly Biosciences·NASDAQ
--
--(--)
--
--(--)
5.99 / 10
Netural
Analyst consensus is overwhelmingly bullish, showing a 100% Strong‑Buy from one firm, though its historical win rate is modest. Fund‑flow analysis scores 7.66 (good), with overall inflow ratio 0.456 but a negative trend, while small‑cap inflows are positive. Sentiment remains neutral.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-26
InstitutionHC Wainwright & Co.
Times predicted3
Historical Win Rate33.3%
What is the analyst consensus for ASMB?
- ASMB holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.99/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
